Jane Street’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$827K Buy
+43,000
New +$847K ﹤0.01% 6916
2025
Q4
Sell
-14,800
Closed -$276K 12220
2025
Q3
$276K Buy
+14,800
New +$276K ﹤0.01% 9068
2025
Q2
Sell
-10,200
Closed -$178K 10739
2025
Q1
$178K Buy
+10,200
New +$172K ﹤0.01% 8532
2024
Q4
Sell
-11,800
Closed -$220K 10434
2024
Q3
$220K Buy
+11,800
New +$199K ﹤0.01% 8522
2021
Q3
Sell
-11,200
Closed -$204K 10619
2021
Q2
$204K Sell
11,200
-8,100
-42% -$144K ﹤0.01% 8789
2021
Q1
$335K Sell
19,300
-42,000
-69% -$739K ﹤0.01% 7518
2020
Q4
$1.06M Sell
61,300
-23,900
-28% -$381K ﹤0.01% 4559
2020
Q3
$1.17M Buy
85,200
+10,000
+13% +$147K ﹤0.01% 3832
2020
Q2
$1.08M Buy
+75,200
New +$989K ﹤0.01% 3942

Other funds holding SBRA

Jane Street's SBRA Position: Q1 2026 in Review

Jane Street reduced its Sabra Healthcare REIT (SBRA) stake by 90% in Q1 2026, selling an estimated $3.63M and leaving 20,469 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #8588.

Jane Street first reported a position in SBRA in Q2 2013 and has held it in 28 quarters since. The position peaked at $7.42M in Q3 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Jane Street held 20,469 shares of Sabra Healthcare REIT worth $394K as of Q1 2026.
  • Jane Street sold 184,246 Sabra Healthcare REIT shares in Q1 2026, an estimated $3.63M.
  • Sabra Healthcare REIT made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8588 holding.
  • Jane Street first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 28 quarters since.
  • Jane Street's Sabra Healthcare REIT position peaked at $7.42M in Q3 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.